147 related articles for article (PubMed ID: 2057535)
1. Sertraline and cocaine-induced locomotion in mice. I. Acute studies.
Reith ME; Wiener HL; Fischette CT
Psychopharmacology (Berl); 1991; 103(3):297-305. PubMed ID: 2057535
[TBL] [Abstract][Full Text] [Related]
2. Sertraline and cocaine-induced locomotion in mice. II. Chronic studies.
Reith ME; Fischette CT
Psychopharmacology (Berl); 1991; 103(3):306-13. PubMed ID: 2057536
[TBL] [Abstract][Full Text] [Related]
3. The chronic effects of desipramine and sertraline on platelet and synaptosomal 5HT uptake in olfactory bulbectomised rats.
Butler J; Tannian M; Leonard BE
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(5):585-94. PubMed ID: 3222448
[TBL] [Abstract][Full Text] [Related]
4. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
Koe BK; Weissman A; Welch WM; Browne RG
J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
[TBL] [Abstract][Full Text] [Related]
5. Cocaine and selective monoamine uptake blockers (sertraline, nisoxetine, and GBR 12935) prevent the d-fenfluramine-induced head-twitch response in mice.
Darmani NA
Pharmacol Biochem Behav; 1998 May; 60(1):83-90. PubMed ID: 9610928
[TBL] [Abstract][Full Text] [Related]
6. Sertraline, a serotonin-uptake inhibitor, reduces food intake and body weight in lean rats and genetically obese mice.
Nielsen JA; Chapin DS; Johnson JL; Torgersen LK
Am J Clin Nutr; 1992 Jan; 55(1 Suppl):185S-189S. PubMed ID: 1728832
[TBL] [Abstract][Full Text] [Related]
7. Differential potentiation of L-tryptophan-induced head-twitch response in mice by cocaine and sertraline.
Darmani NA
Life Sci; 1996; 59(14):1109-19. PubMed ID: 8831798
[TBL] [Abstract][Full Text] [Related]
8. Sertraline: a new specific serotonin reuptake blocker.
Guthrie SK
DICP; 1991 Sep; 25(9):952-61. PubMed ID: 1949975
[TBL] [Abstract][Full Text] [Related]
9. Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands.
Maj J; Rogóz Z; Skuza G
Pol J Pharmacol; 1996; 48(4):379-95. PubMed ID: 9112678
[TBL] [Abstract][Full Text] [Related]
10. Role of central serotonergic neurons in the effect of sertraline in rats in the forced swimming test.
Cervo L; Grignaschi G; Rossi C; Samanin R
Eur J Pharmacol; 1991 Apr; 196(3):217-22. PubMed ID: 1909956
[TBL] [Abstract][Full Text] [Related]
11. Reduction of feeding behavior by the serotonin uptake inhibitor sertraline.
Lucki I; Kreider MS; Simansky KJ
Psychopharmacology (Berl); 1988; 96(3):289-95. PubMed ID: 3146763
[TBL] [Abstract][Full Text] [Related]
12. 5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice.
Reith ME
Eur J Pharmacol; 1990 Sep; 186(2-3):327-30. PubMed ID: 2289534
[TBL] [Abstract][Full Text] [Related]
13. Molecular serotonergic mechanisms appear to mediate genetic sensitivity to cocaine-induced convulsions.
O'Dell LE; Li R; George FR; Ritz MC
Brain Res; 2000 Apr; 863(1-2):213-24. PubMed ID: 10773209
[TBL] [Abstract][Full Text] [Related]
14. An interaction of sertraline and desipramine.
Barros J; Asnis G
Am J Psychiatry; 1993 Nov; 150(11):1751. PubMed ID: 8214190
[No Abstract] [Full Text] [Related]
15. Sertraline: a new antidepressant.
Doogan DP; Caillard V
J Clin Psychiatry; 1988 Aug; 49 Suppl():46-51. PubMed ID: 2842321
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the discriminative stimulus and reinforcing effects of sertraline in rhesus monkeys.
Vanover KE; Nader MA; Woolverton WL
Pharmacol Biochem Behav; 1992 Apr; 41(4):789-93. PubMed ID: 1594647
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant actions on brain noradrenergic neurons.
Valentino RJ; Curtis AL; Parris DG; Wehby RG
J Pharmacol Exp Ther; 1990 May; 253(2):833-40. PubMed ID: 2338658
[TBL] [Abstract][Full Text] [Related]
18. Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake.
Koe BK
J Clin Psychiatry; 1990 Dec; 51 Suppl B():13-7. PubMed ID: 2175308
[TBL] [Abstract][Full Text] [Related]
19. [3H] sertraline binding to rat brain membranes.
Koe BK; Lebel LA; Welch WM
Psychopharmacology (Berl); 1990; 100(4):470-6. PubMed ID: 2138796
[TBL] [Abstract][Full Text] [Related]
20. Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline.
Garattini S; Bizzi A; Caccia S; Mennini T
Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S43-50. PubMed ID: 1338321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
